Skip to main content
. 2021 May 17;62(4):399–407. doi: 10.4111/icu.20200399

Table 2. Comparison of clinical and pathological variables according to expression of phosphorylated PAK4 (pPAK4) and PAK4 in patients with surgically-treated renal cell carcinoma.

Variable pPAK4 expression p-value PAK4 expression p-value
Low High Low High
Patients 56 (42.7) 75 (57.3) 90 (75.6) 29 (24.4)
Mean age (y) 59.5±12.4 59.5±13.1 0.994 60.3±13.0 59.9±12.6 0.218
BMI (kg/m2) 24 ±3.7 24.4±3.4 0.713 24.6±3.5 24.6±3.6 0.955
Sex 0.839 1.000
Male 41 (73.2) 57 (76.0) 66 (73.3) 21 (72.4)
Female 15 (26.8) 18 (24.0) 24 (26.7) 8 (27.6)
Smoking 0.950 0.374
Never 31 (55.4) 40 (53.3) 47 (52.2) 16 (55.2)
Ex-smoker 15 (26.8) 20 (26.7) 26 (28.9) 5 (17.2)
Current 10 (17.9) 15 (20.0) 17 (18.9) 8 (27.6)
DM 12 (21.4) 11 (14.7) 0.358 18 (20.0) 4 (13.8) 0.587
HTN 23 (41.1) 29 (38.7) 0.857 38 (42.2) 8 (27.6) 0.192
Histology 0.274 0.206
Clear cell 50 (89.3) 64 (85.3) 76 (84.4) 27 (93.1)
Papillary 1 (1.8) 6 (8.0) 5 (5.6) 2 (6.9)
Chromophobe 5 (8.9) 5 (6.7) 9 (10.0) 0 (0.0)
Tumor size (mm) 47.3±31.4 60.6±41.2 0.038 54.2±35.8 52.3±36.1 0.803
TNM stage 0.036 0.964
pT1 46 (82.1) 44 (58.7) 64 (71.1) 20 (69.0)
pT2 2 (3.6) 5 (6.7) 5 (5.6) 2 (6.9)
pT3–4 5 (8.9) 13 (17.3) 10 (11.1) 4 (13.8)
Any pT, ≥pN1, or cM1 3 (5.4) 13 (17.3) 11 (12.2) 3 (10.3)
Fuhrman grade 0.002 0.271
1−2 43 (76.8) 37 (49.3) 53 (58.9) 21 (72.4)
3−4 13 (23.2) 38 (50.7) 37 (41.1) 8 (27.6)

Values are presented as number (%) or mean±standard deviation.

p-values were obtained using the Student's t-test and chi-square tests.

PAK4, p21-activated kinases; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; TNM, tumor, nodes, metastasis.